Q3-FY26 · Ritu Mittal
Genomics is not just a point of pride. It is our primary mode against the commodization seen in the routine testing market. In essence we are investing for scale, short-term compression for long-term dominance.
SURAKSHA / language trends
Read confidence between the lines.
Suraksha Diagnostic · tone and specificity signals across the available quarters.
Research layer active
Language signals
What changed in management language.
tracked
Q3-FY26 · Management
The only genomic complete genomic lab in the entire east and northeast belongs to Suraksha.
Q3-FY26 · Management
Q3 margins are always this — the quarter three is the weakest quarter in healthcare. It is almost a given for seasonal thing.
Q3-FY26 · Management
We might be smaller than both Lal and Metropolis but technologically we are at par with anybody in this country today.